Toyota Enters Space Race with Rocket Investment

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 43 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 51%

Business Notícia

Toyota Enters Space Race with Rocket Investment
Space Exploration,Toyota,Rocket Development

Toyota Motor is investing in Interstellar Technologies, a Japanese startup developing orbital launch vehicles, marking the automaker's foray into the space industry. Toyota Chairman Akio Toyoda stated that the company believes the future of mobility extends beyond Earth and aims to leverage its mass production expertise for rocket development.

Toyota Motor is exploring the development and production of orbital rockets, Chairman Akio Toyoda said Monday.

"We are exploring rockets too, because the future of mobility shouldn't be limited to just earth or just one car company, for that matter," Toyoda said during a press conference for CES.The automaker, through its"Woven by Toyota" mobility company, is investing 7 billion Japanese yen into Interstellar Technologies Inc., a Japanese private spaceflight company developing launch vehicles for satellites.

In the Japanese launch market, Toyota is taking on Mitsubishi, whose subsidiary Mitsubishi Heavy Industries has developed and launched the H3 series of rockets for JAXA, the country's space agency. Mitsubishi's H3 rocket, which debuted several years behind schedule, was intended to be priced competitively with SpaceX's Falcon 9 rockets, which dominate the current global launch market.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

nbcchicago /  🏆 545. in PT
 

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Stock Market Drops After Fed Rate Cut, Merck Enters Obesity Drug RaceStock Market Drops After Fed Rate Cut, Merck Enters Obesity Drug RaceThe Federal Reserve cut interest rates by 25 basis points but the market reacted negatively. Merck made a $2 billion deal for an experimental obesity drug.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »